– CNBC
Supernus Late Saturday, Announced New Qelbree Data Showing Improvement In ADHD Symptoms
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, announces the presentation of two